Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.16 USD | +7.46% | -0.92% | -69.23% |
Financials (USD)
Sales 2024 * | 428K | Sales 2025 * | 300K | Capitalization | 6.69M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -33M | EV / Sales 2024 * | 15.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 22.3 x |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-0.56
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.25% |
Latest transcript on TFF Pharmaceuticals, Inc.
1 day | +7.46% | ||
1 week | -0.92% | ||
Current month | -20.88% | ||
1 month | -34.74% | ||
3 months | -68.88% | ||
6 months | -62.47% | ||
Current year | -69.23% |
Managers | Title | Age | Since |
---|---|---|---|
Harlan Weisman
CEO | Chief Executive Officer | 71 | 18-11-30 |
Kirk Coleman
DFI | Director of Finance/CFO | 51 | 18-01-23 |
Zamaneh Mikhak
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-01-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | 18-11-30 | |
Brandi Roberts
BRD | Director/Board Member | 50 | 22-03-24 |
Thomas King
BRD | Director/Board Member | 69 | Dec. 12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 2.16 | +7.46% | 154,264 |
24-05-15 | 2.01 | +8.06% | 50,164 |
24-05-14 | 1.86 | +2.76% | 32,786 |
24-05-13 | 1.81 | -7.18% | 76,533 |
24-05-10 | 1.95 | -10.55% | 27,343 |
Delayed Quote Nasdaq, May 16, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.23% | 6.69M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.11% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- TFFP Stock